Symbol Name ID |
Hic2
hypermethylated in cancer 2 MGI:1929869 |
Reference
|
J:225226 Dykes IM, van Bueren KL, Ashmore RJ, Floss T, Wurst W, Szumska D, Bhattacharya S, Scambler PJ, HIC2 is a novel dosage-dependent regulator of cardiac development located within the distal 22q11 deletion syndrome region. Circ Res. 2014 Jun 20;115(1):23-31 |
Age | E7.5 | E8 | E8.5 | E9.5 | E10 | E10.5 | E11.5 | E13.5 | E15.5 |
Immunohistochemistry (section) | |||||||||
In situ RNA (section) | |||||||||
Immunohistochemistry (whole mount) | |||||||||
In situ RNA (whole mount) | |||||||||
In situ reporter (knock in) | |||||||||
Northern blot | |||||||||
Western blot | |||||||||
RT-PCR | |||||||||
cDNA clones | |||||||||
RNase protection | |||||||||
Nuclease S1 | |||||||||
Primer Extension |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 12/10/2024 MGI 6.24 |
|
|